Lilly to withdraw FDA-approved cancer drug after clinical failure - BioPharma Dive https://t.co/JxXIICWRlU — IDRO (@IDROOhio) April 27, 2019
Lilly to withdraw FDA-approved cancer drug after clinical failure - BioPharma Dive https://t.co/JxXIICWRlU
No comments:
Post a Comment